CONCENTRATIONS |
3 Months Ended |
|---|---|
Mar. 31, 2018 | |
| Notes to Financial Statements | |
| NOTE K - CONCENTRATIONS |
Revenue from one licensee constituted approximately 65% of the Company's revenue for the three months ended March 31, 2018. Revenue from the sale of the Company's unsecured claim against Avaya, Inc. constituted approximately 32% of the Company's revenue for the three monthly ended March 31, 2018. Revenue from one licensee constituted approximately 77% of the Company's revenue for the three months ended March 31, 2017. At March 31, 2018, royalty receivables from three licensees constituted approximately 50%, 13% and 10% of the Company's royalty receivables. At December 31, 2017, royalty receivables from three licensees constituted approximately 79% of the Company's royalty receivables. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|